Data Integrity & Governance
Data Migration Assurance
Migration validation strategy, data completeness verification, audit trail continuity assessment and legacy system decommissioning compliance for pharmaceutical, biotechnology and medical device organisations implementing new systems.
Executive Overview
System transitions — implementing a new eQMS, upgrading a LIMS, replacing an ERP — invariably involve migrating regulated data from legacy systems to new platforms. In pharmaceutical, biotechnology and medical device environments, this migration is not an IT project. It is a GxP activity that must be planned, validated and documented to ensure that regulatory records remain complete, accurate, retrievable and audit trail-intact throughout and after the transition.
Data migration failures carry serious regulatory consequences. Incomplete migration means historical batch records, deviation investigations or CAPA actions may not be accessible when regulators request them. Broken audit trail continuity means the history of regulatory records cannot be fully reconstructed. Premature legacy system decommissioning means records that should be retained for defined periods become inaccessible. Each of these scenarios is a data integrity failure in the eyes of regulatory authorities.
Sthira Assure provides independent data migration assurance for regulated system transitions — from migration planning and validation strategy through to post-migration verification, audit trail continuity assessment and legacy system decommissioning compliance. Our role is to ensure that the compliance requirements of data migration are addressed systematically, with documented evidence that survives regulatory scrutiny.
Applicable Standards
- EU GMP Annex 11 (Computerised Systems)
- FDA 21 CFR Part 11
- GAMP 5 (Data Migration)
- MHRA Data Integrity Guidance
- PIC/S DI Guidance (PI 041)
- EU GMP Chapter 4 (Documentation)
- ICH Q10 (Records Management)
Plan Your Migration
Speak with our team about your system migration and data assurance requirements.
Request a ConsultationCommon Compliance Risks
Data Loss and Incomplete Migration
Data migration failures — truncated records, missing attachments, dropped relationship links between records — represent the most common and most serious migration risk. In regulated environments, incomplete migration means regulatory records are not accessible, audit trail continuity is broken and historical batch records may not be retrievable for the full retention period. Migration completeness verification must be systematic, documented and independently verified before legacy system decommissioning.
Audit Trail Discontinuity
Pharmaceutical quality systems operate on the expectation that the complete history of any record can be retrieved — who created it, who modified it, when, what was changed and why. System migrations frequently break audit trail continuity: historical audit trail data may not be transferred to the new system, audit trail formats may differ between systems and pre-migration records may become read-only without full change history. Inspectors expect audit trail integrity to be maintained across system transitions.
Inadequate Migration Validation
Data migration is a GxP activity that must be validated. Many organisations treat migration as an IT project rather than a compliance project, conducting data migration without formal validation protocols, acceptance criteria or documented reconciliation. When inspectors subsequently request historical records or audit trails, the absence of migration validation evidence — and the inability to guarantee data completeness and accuracy — creates significant compliance exposure.
Premature Legacy System Decommissioning
Legacy systems must remain accessible — or data must be fully migrated and verifiably complete — before decommissioning. Organisations that decommission legacy systems before completing validated migration, or before verifying that all records have been transferred with full audit trail, risk losing access to regulatory records that must be retained for defined periods. Recovery of data from decommissioned systems is expensive, time-consuming and often incomplete.
Scope of Services
Typical Deliverables
Frequently Asked Questions
Does data migration require formal validation in pharmaceutical environments?
Yes. Data migration involving GxP-regulated records is a GxP activity that must be controlled and validated under applicable regulatory requirements. This includes developing a migration plan with acceptance criteria, executing and documenting the migration according to the plan, conducting reconciliation to verify completeness and accuracy, resolving discrepancies systematically, and creating a validation summary report. Regulatory inspectors routinely examine migration validation evidence when reviewing system change history.
How long must pharmaceutical records be retained after a system migration?
Retention requirements depend on the record type and applicable regulatory framework. EU GMP typically requires batch manufacturing records to be retained for one year after product expiry or five years after manufacture (whichever is longer), with minimum one-year post-expiry retention for most GxP records. FDA requirements are broadly similar. Critically, retention periods run from the date of the record, not the date of migration — legacy records must remain accessible throughout their applicable retention period, whether in the new system or in a verified archive.
What is audit trail continuity and why does it matter?
Audit trail continuity means that for any GxP record, the complete history of who created, modified, reviewed or approved it — and when, and what was changed — is available and linked to that record. During system migrations, audit trail continuity is at risk: old audit trail data may not migrate, may migrate in a different format, or may be separated from the records it belongs to. Inspectors who cannot retrieve the complete audit trail for a regulatory record consider this a data integrity failure.
What are the compliance requirements for decommissioning a legacy GxP system?
Before decommissioning a GxP system, the organisation must demonstrate that all records subject to regulatory retention requirements have been migrated to the new system or archived in a validated, accessible format. A decommissioning plan should document the records migrated, the migration validation evidence, the archiving approach for any non-migrated records, the access mechanism for the archive, the period for which the archive will be maintained and the destruction procedure for records that have passed their retention period.
Ensure Your Migration Is Compliant
Contact our team to discuss your system transition requirements and the data migration assurance programme your organisation needs.